Literature DB >> 18212600

Cognitive-behavioral therapy for medication-resistant schizophrenia: a review.

Shanaya Rathod1, David Kingdon, Peter Weiden, Douglas Turkington.   

Abstract

Research meta-analyses have found that cognitive-behavioral therapy (CBT) is beneficial for persistent symptoms of schizophrenia. This review describes and updates the evidence base for this statement. A review of the existing literature (Medline, PsychInfo, and Embase) was carried out according to the guidelines for systematic reviews. Based on the findings of this review, the updated conclusion is that CBT has emerged as an effective adjuvant to antipsychotic medication in the treatment of persistent symptoms of schizophrenia. Studies of the use of CBT in the prodromal phase of psychosis and in combination with family therapy are currently underway.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18212600     DOI： 10.1097/01.pra.0000308492.93003.db

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN： 1527-4160            Impact factor:   1.325


  9 in total

1.  Optimization of Antipsychotic and Benzodiazepine Drugs in Patients with Severe Mental Disorders in an Intensive Case Management Program.

Authors:  María-José Alvarez; Pere Roura-Poch; Nùria Riera; Ana Martín; Clara Blanch; Judit Pons; Josep-Manel Santos; Santiago Escoté
Journal:  Community Ment Health J       Date:  2018-10-23

Review 2.  Adult Neurogenesis and Psychiatric Disorders.

Authors:  Eunchai Kang; Zhexing Wen; Hongjun Song; Kimberly M Christian; Guo-Li Ming
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

3.  Functional hallucinations in schizophrenia responding to adjunctive sodium valproate.

Authors:  Ravi Philip Rajkumar
Journal:  Indian J Psychol Med       Date:  2012-01

4.  Electroconvulsive Therapy in Functional Hallucination: Scope and Challenges.

Authors:  Sulochana Joshi; Rabi Shakya
Journal:  Case Rep Psychiatry       Date:  2017-10-17

5.  Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis.

Authors:  Daniela Polese; Michele Fornaro; Mario Palermo; Vincenzo De Luca; Andrea de Bartolomeis
Journal:  Front Psychiatry       Date:  2019-04-17       Impact factor: 4.157

6.  Current perspectives in the treatment of resistant schizophrenia.

Authors:  R K Solanki; Paramjeet Singh; Deepti Munshi
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

Review 7.  Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care.

Authors:  Wai Tong Chien; Sau Fong Leung; Frederick Kk Yeung; Wai Kit Wong
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-25       Impact factor: 2.570

8.  Cognitive behaviour therapy for psychotic symptoms: a randomized controlled effectiveness trial.

Authors:  Bodil Kråkvik; Rolf W Gråwe; Roger Hagen; Tore C Stiles
Journal:  Behav Cogn Psychother       Date:  2013-05-01

Review 9.  CBT and CFT for Chronic Pain.

Authors:  Graham Hadley; Matthew B Novitch
Journal:  Curr Pain Headache Rep       Date:  2021-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.